Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
An. bras. dermatol ; 94(4): 434-441, July-Aug. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1038295

RESUMEN

Abstract: Background: In-vitro studies showed that Leucine-rich glioma inactivated 3 (LGI3) is a keratinocyte-derived cytokine that stimulates melanin synthesis and is increased after ultra violet B (UVB) irradiation. So, we postulated that LGI3 may be involved in vitiligo aetiopathogenesis and may participate in narrow band ultra violet B (NB-UVB) induced pigmentation in vitiligo. Objectives: To assess this hypothesis, lesional LGI3 immunohistochemical expression of vitiligo patients before and after NB-UVB phototherapy was studied, and its correlation with repigmentation was evaluated. Methods: Forty vitiligo patients and 20 age, sex, and skin phenotype-matched controls were enrolled. Patients were treated with NB-UVB thrice weekly for 12 weeks. VASI score was evaluated before and after NB-UVB sessions. For vitiligo patients, baseline LGI3 immunohistochemical staining was estimated, and compared to that of controls and to its post-treatment data in those patients. Results: Baseline LGI3 immunohistochemical studied parameters (expression, intensity, percentage and H score) were significantly lower in vitiligo cases than controls (p=0.003, 0.013, 0.001 and 0.001 respectively). After 12 weeks of NB-UVB phototherapy, these LGI3 immunohistochemical parameters were up-regulated and became comparable to that of controls (p >0.05 for all). There was a significant positive correlation between the improvement of both VASI score and LGI3 H score mean values (r=-0.349 , p=0.027). Study limitations: Small number of investigated subjects. Conclusions: Decreased LGI3 protein may play an active role in vitiligo pathogenesis and its up-regulation after NB-UVB phototherapy, may actively participate in NB-UVB photo-induced melanogenesis.


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Adulto , Persona de Mediana Edad , Adulto Joven , Terapia Ultravioleta/métodos , Vitíligo/patología , Vitíligo/radioterapia , Proteínas/análisis , Citocinas/análisis , Valores de Referencia , Factores de Tiempo , Índice de Severidad de la Enfermedad , Inmunohistoquímica , Estudios de Casos y Controles , Queratinocitos/efectos de la radiación , Resultado del Tratamiento , Estadísticas no Paramétricas , Melanocitos/efectos de la radiación
2.
Arq. bras. oftalmol ; 82(2): 103-106, Mar.-Apr. 2019. tab
Artículo en Inglés | LILACS | ID: biblio-989399

RESUMEN

ABSTRACT Purpose: To report our initial experience in the treatment of Acanthamoeba keratitis with accelerated corneal collagen cross-linking. Methods: Retrospective chart review of patients diagnosed with Acanthamoeba keratitis with progressive corneal melting who were treated with accelerated collagen cross-linking. Results: A total of 6 eyes (5 patients) were reviewed. All the patients received adjuvant therapy with moxifloxacin and chlorhexidine. In 4 cases, the ulcer healed with a mean interval to epithelialization of 108.8 days (range 59-217). In 2 eyes, there was a persistent neurotrophic ulcer. The melting was not progressive in any case, nor did any eye required emergency penetrating keratoplasy. Conclusion: This study suggests a beneficial effect of accelerated collagen cross-linking in cases of Acanthamoeba keratitis with corneal melting. Thus, collagen cross-linking may be considered as adjuvant treatment for Acanthamoeba keratitis.


RESUMO Objetivo: Relatar nossa experiência inicial no tra tamento da ceratite por Acanthamoeba com reticulação acelerada de colágeno corneano. Métodos: Revisão retrospectiva de prontuários de pacientes diagnosticados com ceratite por Acanthamoeba, com deformação progressiva da córnea, tratados com reticulação acelerada de colágeno. Resultados: Seis olhos (5 pacientes) foram incluídos. Todos os pacientes receberam terapia adjuvante com moxifloxacina e clorexidina. Em 4 casos, a úlcera cicatrizou com uma média de epitelização de 108,8 dias (amplitude de 59-217 dias). Em dois pacientes, a úlcera apresentou um comportamento neurotrófico. A deformação não foi progressiva em nenhum dos pacientes e nenhum dos olhos exigiu ceratoplastia penetrante de emergência. Conclusão: Este estudo sugeriu um efeito benéfico da reticulação acelerada de colágeno em casos de ceratite por Acanthamoeba infecciosa com deformação corneal. A reticulação de colágeno parece ser uma alternativa coadjuvante possível para casos de ceratite por Acanthamoeba.


Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Riboflavina/uso terapéutico , Terapia Ultravioleta/métodos , Queratitis por Acanthamoeba/terapia , Colágeno/metabolismo , Fármacos Fotosensibilizantes/uso terapéutico , Reactivos de Enlaces Cruzados/uso terapéutico , Queratitis por Acanthamoeba/metabolismo , Úlcera de la Córnea/metabolismo , Úlcera de la Córnea/terapia , Estudios de Seguimiento , Colágeno/efectos de los fármacos , Colágeno/efectos de la radiación , Córnea/efectos de los fármacos , Córnea/efectos de la radiación , Córnea/metabolismo
3.
Zagazig univ. med. j ; 25(3): 326-334, 2019. ilus
Artículo en Inglés | AIM | ID: biblio-1273859

RESUMEN

Background: Vitiligo is a skin disease with complex, multifactorial pathogenesis. Abnormalities in surrounding keratinocytes may cause melanocyte death due to deprivation of growth factors. Narrow band ultraviolet B (NB-UVB) is an effective therapeutic option especially in patients with generalized disease.Objective: The aim of this study was to identify histopathological changes in lesional and perilesional skin of vitiligo patients and the effect of NB-UVB therapy on them.Methods: Twenty patients were enrolled in this study. They received NB-UVB twice weekly on non-consecutive days for a total of 40 sessions. Skin biopsies from lesional and perilesional skin were obtained from each patient before and after therapy.Results: After therapy, 10% of patients showed excellent clinical response, 10% showed good response, 40% showed moderate response, 35% showed poor response and 5% showed progressive disease. Before therapy, 50% of patients showed a basal lymphocytic infiltrate with a perivascular lymphocytic infiltrate in both lesional and perilesional skin. 40% of them showed additional hydropic degeneration of lower epidermis with apoptotic keratinocytes in 20% of them. After therapy, these inflammatory changes were significantly reduced (p=0.04).Conclusion: NB-UVB is an effective method of treatment of vitiligo. This may be due to its immunosuppressive effects. Also, keratinocyte apoptosis may have a role in pathogenesis of vitiligo


Asunto(s)
Apoptosis , Egipto , Queratinocitos , Terapia Ultravioleta/métodos , Vitíligo/terapia
4.
An. bras. dermatol ; 93(3): 385-390, May-June 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-949872

RESUMEN

Abstract: BACKGROUND: Narrow-band UVB (NB-UVB) has been shown to be one of the most effective treatment modalities for psoriasis. Tazarotene, a known effective anti-psoriatic modality, when combined with NB-UVB may enhance the therapeutic success. OBJECTIVE: To study clinical efficacy and safety of combination of NB-UVB with topical tazarotene 0.05% gel in psoriasis. METHOD: Thirty patients with plaque psoriasis having symmetrical lesions were enrolled for 12 weeks. All patients were instructed to apply tazarotene gel on target plaque on left side of body once daily. In addition, the whole body was irradiated with NB-UVB twice weekly. Efficacy was assessed by target plaque scoring and number of treatment sessions for clearance. RESULT: Our study resulted in 3 key findings: Firstly, therapeutic efficacy of NB-UVB was enhanced by addition of tazarotene. This enhanced efficacy was more apparent in decreasing scaling and thickness as compared to decrease in erythema. Secondly, combination therapy showed faster clearance of target plaques, with reduction in mean number of treatment sessions. Thirdly, mean cumulative NB-UVB dose needed to achieve clearance of target plaques was significantly reduced with combination therapy. STUDY LIMITATIONS: The study was not randomized or controlled, but an open-label trial. The study period was relatively short, i.e., 12 weeks, without any follow-up period. CONCLUSION: Tazarotene gel significantly enhances the therapeutic efficacy of NB-UVB irradiation with faster clearance and without serious side effects.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Adulto Joven , Psoriasis/radioterapia , Terapia Ultravioleta/métodos , Estudios de Seguimiento , Fármacos Dermatológicos/administración & dosificación , Psoriasis/tratamiento farmacológico , Factores de Tiempo , Estudios Prospectivos , Resultado del Tratamiento , Terapia Combinada/métodos , Ácidos Nicotínicos/administración & dosificación
5.
Rev. chil. dermatol ; 34(1): 32-35, 2018. ilus
Artículo en Español | LILACS | ID: biblio-965818

RESUMEN

El Penfigoide nodular es una variante clínica poco frecuente de penfigoide buloso. Corresponde a una dermatosis ampollar subepidérmica, crónica, autoinmune, caracterizada por auto anticuerpos contra antígenos específicos de hemidesmosomas en la unión dermo-epidérmica. Su incidencia es desconocida. La etiopatogenia aún no es entendida del todo. Se presenta clínicamente como una superposición de características de pénfigo buloso y prurigo nodular. El diagnóstico se basa en hallazgos clínicos e inmunopatológicos. La histopatología con inmunofluorescencia directa es el gold standard para el diagnóstico. El manejo es difícil, tiene mala respuesta a corticoides potentes locales, siendo necesario el uso de corticoides sistémicos y diferentes inmunosupresores solos o combinados junto a antihistamínicos para el manejo de prurito intenso. Se presenta un caso de pénfigo nodular, donde destaca su buena respuesta a terapia combinada con metotrexato y luz UVB de banda angosta.


Pemphigoid Nodularis is a rare clinical variant of bullous pemphigoid. It is considered an autoimmune, chronic, subepidermal blistering dermatosis, characterized by antibodies against hemidesmosome-specific antigens at the dermo-epidermal junction. Its incidence is unknown and its etiopathogenetic not fully understood. Clinically, it presents with overlapping features of bullous pemphigoid and prurigo nodularis. The diagnosis is based on clinical and immunopathological findings, being the histopathological study with immunofluorescence the gold standard. The management is difficult; since it has a poor response to local potent corticosteroids, requiring the use of systemic corticosteroids and different immunosuppressants alone or combined with antihistamines for the intense pruritus. We present a case of nodularis pemphigoid, highlighting the good response to the combination of methotrexate and phototherapy with narrow band UVB.


Asunto(s)
Humanos , Femenino , Anciano , Terapia Ultravioleta/métodos , Penfigoide Ampolloso/terapia , Biopsia , Ensayo de Inmunoadsorción Enzimática , Metotrexato/uso terapéutico , Penfigoide Ampolloso/patología , Terapia Combinada
6.
An. bras. dermatol ; 92(6): 801-806, Nov.-Dec. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-887121

RESUMEN

Abstract: Background: Narrow-band UVB is the most innovative steroid sparing treatment in atopic dermatitis. There are studies showing efficacy of Narrow-band UVB in childhood atopic dermatitis, but there is lack of clinical trials in the literature determining the length of remission. Therefore, we sought to highlight its efficacy, safety and its post-treatment efficacy in childhood atopic dermatitis. Objective: To assess the clinical efficacy, safety of Narrow-band UVB in the treatment of paediatric atopic dermatitis and length of remission during 2 years of post-treatment follow-up. Methods: Thirty children (4-14 years) having moderate to severe AD (SCORAD index > 25) were enrolled for 12 weeks. Narrow-band UVB phototherapy was administered twice a week on non-consecutive days for three months. SCORAD index was calculated by the same dermatologist at baseline, 6th, 12th, 18th and 24th treatment session. Secondary outcomes were measured using visual analog scale for pruritus and sleep loss. Patients were also followed-up for 2 years to know the length of remission after end of therapy. Results: There was a significant reduction in SCORAD index at 6th, 12th, 18th and 24th treatment session in comparison to baseline. This improvement in SCORAD was also maintained during the 2 years of post-treatment follow-up period. Consequently, pruritus and sleep loss improved significantly from baseline to end of therapy and even during the 1st and 2nd year of follow-up. Study limitation: Open-label trial without control group. Conclusions: Narrow-band UVB is an efficacious and safe modality of treatment in childhood atopic dermatitis with good therapeutic index and minimal side effects.


Asunto(s)
Humanos , Masculino , Preescolar , Niño , Adolescente , Terapia Ultravioleta/métodos , Dermatitis Atópica/radioterapia , Prurito/radioterapia , Factores de Tiempo , Índice de Severidad de la Enfermedad , Estudios Prospectivos , Reproducibilidad de los Resultados , Análisis de Varianza , Estudios de Seguimiento , Resultado del Tratamiento , Escala Visual Analógica
7.
Arq. bras. oftalmol ; 80(2): 93-96, Mar.-Apr. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-838788

RESUMEN

ABSTRACT Purpose: We aimed to report and analyze topographic and refractive outcomes following corneal collagen crosslinking (CXL) in patients with progressive keratoconus (KC). Methods: We performed a retrospective, analytical, and observational study of 100 eyes from 74 progressive KC patients who underwent CXL at the Eye Hospital of Paraná. Keratometric values were analyzed preoperatively as well as 3 and 12 months postoperatively. Results: For a total of 100 eyes, 68 belonged to male patients. The mean age of our study population was 19.9 ± 5.61 years. The average visual acuity and topographic parameters overall were stable after 1 year (p<0.05). After 3 months, steepest keratometry reading (K2) and maximum keratometry (Kmax) were significantly decreased (p<0.05). Regarding topographic astigmatism (dK), there was no significant difference between the 3-month and 12-month follow-ups. When we made comparisons between genders following CXL, there were no significant differences related to the changes in Kmax, K2, and spectacle-corrected distance visual acuity (SCDVA). Conclusions: CXL promoted stabilization or improvement of keratometric values and visual acuity. We found that keratoconus apex stability may be achieved 3 months after the procedure. There was no significant difference in keratometric and refractive values measured between male and female patients.


RESUMO Objetivos: Relatar e analisar os resultados topográficos e refracionais após crosslinking de colágeno corneano (CXL) em pacientes com ceratocone (KC) progressivo. Métodos: Estudo retrospectivo analítico e observacional incluindo 100 olhos de 74 pacientes com KC progressivo submetidos a CXL no Hospital de Olhos do Paraná. Valores ceratométricos foram analisados no pré-operatório, 3 e 12 meses de pós-operatório. Resultados: Em um total de 100 olhos, 68 eram do sexo masculino. A idade média foi de 19,9 ± 5,61. As médias de parâmetros topográficos e acuidade visual em geral, tiveram estabilidade após 1 ano de follow-up (p<0,05). Após 3 meses, a ceratometria mais curva (K2) e a ceratometria máxima (Kmax) tiveram reduções estatisticamente significativas (p<0,05). Em relação ao astigmatismo topográfico (dK), não houve diferença estatisticamente significativa aos 3 e 12 meses de seguimento. Comparando ambos os sexos após o procedimento, não houve diferenças estatisticamente significativas relacionadas às mudanças em Kmax, K2 e acuidade visual corrigida. Conclusões: CXL promoveu a estabilidade ou melhora dos valores ceratométricos e da acuidade visual. Encontramos que a estabilidade do ápice do KC pode ser obtida nos três primeiros meses de follow-up. Não houve diferença estatisticamente significativa nos valores topográficos e refracionais medidos entre pacientes do sexo masculino e feminino.


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Adulto , Adulto Joven , Colágeno/uso terapéutico , Topografía de la Córnea/estadística & datos numéricos , Reactivos de Enlaces Cruzados/uso terapéutico , Queratocono/terapia , Refracción Ocular/fisiología , Terapia Ultravioleta/métodos , Cuidados Preoperatorios , Agudeza Visual/fisiología , Factores Sexuales , Estudios Retrospectivos , Estudios de Seguimiento , Resultado del Tratamiento , Progresión de la Enfermedad , Queratocono/fisiopatología
8.
An. bras. dermatol ; 92(5,supl.1): 82-84, 2017. graf
Artículo en Inglés | LILACS | ID: biblio-887055

RESUMEN

Abstract Granuloma annulare is a benign cutaneous inflammatory disease, whose lesions have spontaneous improvement in two years in 50% of cases, but there is recurrence in 40% of patients. Treatment may be topical, intralesional or systemic. The use of phototherapy with narrowband UVB is highlighted, whose mechanism of action in this disease is still unclear, probably related to the inhibition of T lymphocytes. Herein, a case of a disseminated granuloma annulare of difficult therapeutic management is described. It was treated with narrowband UVB phototherapy twice a week for six months, with good clinical improvement, being a good low-risk therapeutic option and that, in this case, provided quick and satisfactory response.


Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Terapia Ultravioleta/métodos , Granuloma Anular/radioterapia , Resultado del Tratamiento , Granuloma Anular/patología , Eritema/patología , Eritema/radioterapia
9.
An. bras. dermatol ; 91(5): 580-583, Sept.-Oct. 2016. tab, graf
Artículo en Inglés | LILACS | ID: biblio-827748

RESUMEN

Abstract: Background: C-reactive protein is an inflammatory biomarker and its level increases in the serum of psoriatic patients. Its level is also associated with Psoriasis Area and Severity Index score. Objective: The aim of this study was to assess the decrement of serum C-reactive protein level with narrow-band ultraviolet B (NB-UVB) therapy. Methods: C-reactive protein serum levels in psoriasis patients were measured before and after treatment with NB-UVB and the data were analyzed in relation to the Psoriasis Area and Severity Index score improvement. Results: Baseline C-reactive protein levels among psoriatic patients were higher than normal. These levels decreased significantly after treatment (P<0.001). At the beginning of the study, patients with higher levels of C-reactive protein also had more extensive and severe skin involvement. The highest decrease in C-reactive protein was observed in patients who responded better to the treatment and achieved a higher Psoriasis Area and Severity Index 75%. There was an association between baseline Psoriasis Area and Severity Index scores and C-reactive protein levels. Conclusion: Patients with moderate to severe plaque-type psoriasis had active systemic inflammation, which was demonstrated by increased levels of C-reactive protein. Furthermore, skin disease severity was correlated with C-reactive protein levels. Phototherapy healed the psoriatic skin lesions and reduced inflammation, while decreasing C-reactive protein levels.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Adulto Joven , Psoriasis/radioterapia , Terapia Ultravioleta/métodos , Proteína C/análisis , Psoriasis/sangre , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
10.
Braz. j. med. biol. res ; 49(8): e5354, 2016. tab
Artículo en Inglés | LILACS | ID: lil-787380

RESUMEN

Glycyrrhizin has been used clinically for several years due to its beneficial effect on immunoglobulin E (IgE)-induced allergic diseases, alopecia areata and psoriasis. In this study, glycyrrhizin, ultraviolet B light (UVB) or a combination of both were used to treat active-stage generalized vitiligo. One hundred and forty-four patients between the ages of 3 and 48 years were divided into three groups: group A received oral compound glycyrrhizin (OCG); group B received UVB applications twice weekly, and group C received OCG+UVB. Follow-ups were performed at 2, 4, and 6 months after the treatment was initiated. The Vitiligo Area Scoring Index (VASI) and the Vitiligo Disease Activity (VIDA) instrument were used to assess the affected body surface, at each follow-up. Results showed that 77.1, 75.0 and 87.5% in groups A, B and C, respectively, presented repigmentation of lesions. Responsiveness to therapy seemed to be associated with lesion location and patient compliance. Adverse events were limited and transient. This study showed that, although the three treatment protocols had positive results, OCG and UVB combination therapy was the most effective and led to improvement in disease stage from active to stable.


Asunto(s)
Humanos , Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Adulto Joven , Fármacos Dermatológicos/uso terapéutico , Ácido Glicirrínico/uso terapéutico , Terapia Ultravioleta/métodos , Vitíligo/terapia , Administración Oral , Terapia Combinada/métodos , Estudios de Seguimiento , Calidad de Vida , Índice de Severidad de la Enfermedad , Pigmentación de la Piel , Comprimidos , Resultado del Tratamiento , Vitíligo/clasificación
11.
An. bras. dermatol ; 90(4): 473-478, July-Aug. 2015. tab, ilus
Artículo en Inglés | LILACS | ID: lil-759201

RESUMEN

AbstractBACKGROUND:For years, phototherapy has been used in a wide range of skin diseases, which is unsurprising as skin is the anatomical feature most directly exposed to light, especially in psoriasis. Although the role of light therapy has been replaced by different therapeutic modalities in recent years, this treatment is now an established option for many skin diseases.OBJECTIVES:The aim was to characterize the patient population thathad received the aforementioned treatment in the Virgen Macarena Health Area in Seville (Spain) between June 1985 and October 2011.METHODS:We have designed a descriptive study with a univariate analysis covering 443 treatments with light therapy, all administered to the same number of patients suffering from psoriasis.RESULTS:79.15% of patients were discharged due to improvement or healing, while the 20.85% were discharged due to other reasons. The average total accumulative dose was 131.53 J/cm2. We do not detected an increase in proportion in patients for develop NMSK after light therapy treatment.CONCLUSIONS:We consider that phototherapy is still an effective and efficient treatment that will have to be reconsidered in the current macroeconomic context.


Asunto(s)
Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Psoriasis/radioterapia , Terapia Ultravioleta/métodos , Distribución por Edad , Hospitales de Enseñanza , Dosis de Radiación , Distribución por Sexo , España , Estadísticas no Paramétricas , Factores de Tiempo , Resultado del Tratamiento
13.
Rev. chil. pediatr ; 86(2): 121-125, abr. 2015. ilus, tab
Artículo en Español | LILACS | ID: lil-752890

RESUMEN

Introducción: La pitiriasis liquenoide es una enfermedad inflamatoria benigna de causa desconocida. Tiene dos formas de presentación: una forma aguda (PLEVA, pitiriasis liquenoide y varioliforme aguda) y otra crónica (PLC, pitiriasis liquenoide crónica). Ambas son más frecuentes en niños y adultos jóvenes. Objetivo: Describir un caso de PLC, comentar su presentación clínica, diagnóstico y tratamiento, y revisar la literatura. Caso clínico: Escolar de 7 años que presentó episodios recurrentes de lesiones tipo pápulas eritematocostrosas brillantes de distribución centrípeta, oligosintomáticas, que desaparecían dejando máculas hipopigmentadas. La biopsia de las lesiones confirmó una pitiriasis liquenoide crónica. Durante los 3 años de seguimiento se realizaron múltiples esquemas de tratamiento para atenuar las reagudizaciones, logrando una respuesta parcial. Conclusión: La PLC es una enfermedad infrecuente que representa un desafío diagnóstico y terapéutico para el médico. El diagnóstico de esta entidad se sospecha por la clínica y se confirma con la histología. No tiene tratamiento específico pero presenta buena respuesta a corticoides, antibióticos, inmunosupresores y fototerapia UVB de banda angosta (UVB-nb). Esta última es la que ha reportado los mejores resultados. Es importante el seguimiento de los pacientes por el riesgo de desarrollar enfermedades linfoproliferativas.


Introduction: Pityriasis lichenoides is a benign inflammatory disease of unknown etiology. There are two types of this condition: an acute form (PLEVA = pityriasis lichenoides et varioliformis acuta) and a chronic one (PLC = pityriasis lichenoid chronica). Both are more common in children and young adults. Objective: To describe a case of PLC, discuss its clinical presentation, diagnosis, treatment and present a review of the literature. Case Report: A seven-year-old child who presented with recurrent oligosymptomatic episodes of bright erythematous papular lesions in centripetal distribution, which subsided and left behind hypopigmented macules. The biopsy of the lesions confirmed chronic pityriasis lichenoid. During the 3 years of follow-up, multiple treatment regimens were used to reduce exacerbations, resulting in a partial response. Conclusion: PLC is a rare disease that represents a diagnostic and therapeutic challenge to the physician. The diagnosis of this condition is suspected clinically and confirmed by histology. It does not have specific treatment, but it responds well to corticosteroids, antibiotics, immunosuppressants and phototherapy with UVB narrowband (UVBnb). The latter has given the best results. It is important to monitor patients for risk of developing lymphoproliferative disorders.


Asunto(s)
Humanos , Masculino , Niño , Terapia Ultravioleta/métodos , Pitiriasis Liquenoide/diagnóstico , Biopsia , Enfermedad Crónica , Resultado del Tratamiento , Pitiriasis Liquenoide/patología , Pitiriasis Liquenoide/terapia , Corticoesteroides/uso terapéutico , Cuidados Posteriores , Antibacterianos/uso terapéutico
14.
Rev. cuba. oftalmol ; 27(4): 569-575, oct.-dic. 2014. tab
Artículo en Español | LILACS, CUMED | ID: lil-746394

RESUMEN

OBJETIVO: determinar las variaciones de la elevación anterior y posterior de la córnea con el tratamiento de crosslinking corneal en pacientes con queratocono en el Servicio de Córnea del Instituto Cubano de Oftalmología "Ramón Pando Ferrer". MÉTODOs: se realizó un estudio descriptivo, retrospectivo, a 30 ojos de 30 pacientes con queratocono a los cuales se les realizó el crosslinking corneal. Se recogieron los datos en el preoperatorio a los 6, 12 y 24 meses. Las variables estudiadas fueron: esfera mejor ajustada anterior, elevación anterior, esfera mejor ajustada posterior y elevación posterior. RESULTADOS: la esfera mejor ajustada anterior en el preoperatorio de 7,34 mm permaneció sin diferencia significativa en el posoperatorio y la elevación anterior mostró una reducción estadísticamente significativa de 20,73 µm en el preoperatorio a 14,90 µm al año y 15,93 µm a los 2 años. La esfera de mejor ajuste posterior de 5,94 mm no sufrió modificaciones en el posoperatorio, ni la elevación posterior media de 31,80 µm. CONCLUSIONES: después del crosslinking corneal la elevación anterior disminuye y la posterior se mantiene igual.


OBJECTIVE: to determine the anterior and posterior corneal surface elevation in the corneal crosslinking surgical treatment applied to patients with keratoconus at the corneal service of "Ramón Pando Ferrer" Cuban Institute of Ophthalmology. METHODS: a retrospective and descriptive study of 30 eyes from 30 patients with progressive keratoconus who underwent the corneal collagen crosslinking. Data were collected preoperatively at 6, 12 and 24 months. The studied variables were best fit anterior sphere, anterior elevation, best posterior fit sphere and posterior corneal elevation. RESULTS: the preoperative best fit anterior sphere was 7,34 mm and there was no difference in the postoperative period. The anterior corneal surface elevation showed statistically significant reduction from 20,73 µm in the preoperative period to 14,90 µm in the first year and 15,93 µm in the second year after surgery. There was no changes either in the posterior best fit sphere of 5,94 mm or in the posterior elevation of 31,80 µm. CONCLUSIONS: after the corneal crosslinking, there is a reduction of the anterior elevation and the posterior elevation remains the same.


Asunto(s)
Humanos , Terapia Ultravioleta/métodos , Córnea/efectos de la radiación , Queratocono/radioterapia , Epidemiología Descriptiva , Estudios Prospectivos , Estudio Observacional
15.
Indian J Dermatol Venereol Leprol ; 2014 Nov-Dec; 80(6): 505-508
Artículo en Inglés | IMSEAR | ID: sea-154882

RESUMEN

Background: Early lesions of vitiligo can be confused with various other causes of hypopigmentation and depigmentation. Few workers have utilized dermoscopy for the diagnosis of evolving lesions of vitiligo. Aim: To analyze the dermoscopic findings of evolving lesions in diagnosed cases of vitiligo and to correlate them histopathologically. Methods: Dermoscopy of evolving lesions in 30 diagnosed cases of vitiligo was performed using both polarized light and ultraviolet light. Result: On polarized light examination, the pigmentary network was found to be reduced in 12 (40%) of 30 patients, absent in 9 (30%), and reversed in 6 (20%) patients; 2 patients (6.7%) showed perifollicular hyperpigmentation and 1 (3.3%) had perilesional hyperpigmentation. A diffuse white glow was demonstrable in 27 (90%) of 30 patients on ultraviolet light examination. Melanocytes were either reduced in number or absent in 12 (40%) of 30 patients on histopathology. Conclusion: Pigmentary network changes, and perifollicular and perilesional hyperpigmentation on polarized light examination, and a diffuse white glow on ultraviolet light examination were noted in evolving vitiligo lesions. Histopathological examination was comparatively less reliable. Dermoscopy appears to be better than routine histopathology in the diagnosis of evolving lesions of vitiligo and can obviate the need for a skin biopsy.


Asunto(s)
Dermoscopía/métodos , Dermoscopía/estadística & datos numéricos , Humanos , Hiperpigmentación/diagnóstico , /radioterapia , Selección de Paciente , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Enfermedades Cutáneas Papuloescamosas/radioterapia , Terapia Ultravioleta/métodos , Vitíligo/diagnóstico , Vitíligo/radioterapia
16.
Arq. bras. oftalmol ; 77(5): 310-314, Sep-Oct/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-730374

RESUMEN

Objective: To evaluate the effect of riboflavin-ultraviolet-A-induced cross-linking (CXL) following corneal alkali burns in rabbits. Methods: The right corneas and limbi of ten rabbits were burned using a 1N solution of NaOH and the animals were then divided into two groups: a control group submitted to clinical treatment alone and an experimental group that was treated 1 h after injury with CXL, followed by the same clinical treatment as administered to the controls. Clinical parameters were evaluated post-injury at 1, 7, 15, and 30 days by two independent observers. Following this evaluation, the corneas were excised and examined histologically. Results: There were no statistically significant differences in clinical parameters, such as hyperemia, corneal edema, ciliary injection, limbal ischemia, secretion, corneal neovascularization, symblepharon, or blepharospasm, at any of the time-points evaluated. However, the size of the epithelial defect was significantly smaller in the CXL group (p<0.05) (day 15: p=0.008 and day 30: p=0.008) and the extent of the corneal injury (opacity lesion) was also smaller (day 30: p=0.021). Histopathology showed the presence of collagen bridges linking the collagen fibers in only the CXL group. Conclusions: These results suggest that the use of CXL may improve the prognosis of acute corneal alkali burns. .


Objetivo: Avaliar o efeito de ligações covalentes de colágeno (cross-linking [CXL]) induzidas pelo tratamento com riboflavina e radiação ultravioleta A após queimaduras por álcali em córneas de coelhos. Métodos: Dez coelhos foram submetidos a queimadura ocular direita abrangendo estruturas da córnea e limbo usando uma solução de NaOH a 1N. A seguir, os animais foram divididos em dois grupos: um grupo controle submetido a tratamento clínico pós dano corneano e um grupo experimental que foi tratado com CXL uma hora após o dano, seguido pelo mesmo tratamento clínico administrado aos controles. Os parâmetros clínicos foram avaliados 1, 7, 15 e 30 dias após a lesão, por dois observadores independentes. Na etapa seguinte, foi realizada a excisão e o exame histológico das córneas. Resultados: Não houve diferenças estatisticamente significantes nos parâmetros clínicos de hiperemia, edema da córnea, injeção ciliar, isquemia límbica, secreção, neovascularização da córnea, simbléfaro ou blefaroespasmo, em qualquer dos momentos da avaliação. Entretanto, o grupo CXL apresentou um defeito epitelial menor (p<0,05) (dia 15: p=0,008 e dia 30: p=0,008) e menor extensão da lesão na córnea (lesão opaca) (dia 30: p=0,021). O exame histopatológico revelou a presença de pontes de colágeno conectando as fibras de colágeno somente no grupo CXL. Conclusões: Estes resultados sugerem que o uso de CXL pode melhorar o prognóstico de queimaduras agudas da córnea causadas por alcáli. .


Asunto(s)
Conejos , Riboflavina , Terapia Ultravioleta/métodos , Córnea/efectos de los fármacos , Reactivos de Enlaces Cruzados
18.
Rev. cuba. pediatr ; 86(2): 134-146, abr.-jun. 2014. ilus
Artículo en Español | LILACS | ID: lil-721312

RESUMEN

INTRODUCCIÓN: deficiencias en los mecanismos de reparación del ácido desoxirribonucleico constituyen un factor de riesgo para el desarrollo del cáncer, como ocurre en el xeroderma pigmentoso. OBJETIVOS: evaluar el fenotipo de la reparación por escisión de nucleótidos en pacientes cubanos con una elevada hipersensibilidad al sol, y la sospecha clínica de xeroderma pigmentoso en la fase eritematopigmentaria, mediante la variante alcalina del ensayo cometa. MÉTODOS: se estudiaron 28 pacientes, con predominio de las edades pediátricas. Como inductor del daño al ácido desoxirribonucleico se utilizó la radiación ultravioleta C (254 nm) a una dosis de 40 J/m². El daño del ácido desoxirribonucleico se cuantificó inmediatamente, después de irradiar las células (tiempo 0 minutos) y un tiempo después de la irradiación, incubado a 37 ºC en medio de cultivo, enriquecido con suero fetal al 10 % (tiempo 45 min). Con estos datos se determinó el por ciento de la diferencia en las unidades arbitrarias (UA) entre ambos momentos. RESULTADOS: no se obtuvieron diferencias significativas (p= 0,080976) entre el grupo de pacientes (224,23 UA) y el grupo de sujetos controles (195,43 UA). Los pacientes reconocieron y escindieron el daño inducido en el ácido desoxirribonucleico por luz ultravioleta C, con una eficiencia similar a la de los controles. CONCLUSIONES: el ensayo cometa alcalino acoplado a radiación ultravioleta C permitió identificar, claramente y de forma indirecta, el funcionamiento de los mecanismos de reparación por escisión de nucleótidos, donde actúan las proteínas XPA a XPG. Los sujetos en estudio fueron excluidos de presentar la forma clásica de la enfermedad.


INTRODUCTION: deficiencies in the deoxyribonucleic acid repair mechanisms are a risk factor for cancer as is the case of xeroderma pigmentosum. OBJECTIVES: to evaluate the phenotype of nucleotide excision repair in Cuban sun hypersensitive patients with clinical suspicion of xeroderma pigmentosum at erythematopigmentary phase, by using the Comet assay alkaline variant. METHODS: twenty eight patients mainly at pediatric ages were studied. The used DNA damage inducer was ultraviolet radiation C (254 nm) at 40 J/m2 dose. The DNA damage was quantified immediately after cell irradiation (0 minutes) and some time afterwards, then cultured at 37 ºC and enriched with 10 % fetal serum (45 minutes). This data allowed determining the percentage of difference in arbitrary units (AU) between both moments. RESULTS: there was no significant differences (p= 0.080976) between the group of patients (224.23 AU) and the control group (195.43 UA). The UV-C induced DNA damage was recognized and excised in the patients with similar effectiveness to that of the controls. CONCLUSIONS: the UV-C radiation-coupled alkaline comet assay allowed clearly and indirectly identifying the functioning of the nucleotide excision repair mechanisms in which XPA to XPG proteins influence. The studied subjects did not show the classical form of this disease.


Asunto(s)
Humanos , Luz Solar/efectos adversos , Terapia Ultravioleta/métodos , ADN , Reparación del ADN/fisiología , Trastornos por Deficiencias en la Reparación del ADN/prevención & control , Hipersensibilidad/diagnóstico
19.
Indian J Hum Genet ; 2013 Oct-Dec ;19 (4): 487-490
Artículo en Inglés | IMSEAR | ID: sea-156621

RESUMEN

Dyschromatosis universalis hereditaria (DUH) is a rare genodermatosis reported initially and mainly in Japan. However, subsequent cases have been reported from other countries. We report a case of DUH in a south Indian woman with a positive family history with cosmetic disfigurement and severe psychological impairment.


Asunto(s)
Adulto , Femenino , Humanos , India , Trastornos Mentales/epidemiología , Trastornos de la Pigmentación/epidemiología , Trastornos de la Pigmentación/genética , Trastornos de la Pigmentación/psicología , Trastornos de la Pigmentación/radioterapia , Enfermedades Cutáneas Genéticas/epidemiología , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Genéticas/psicología , Enfermedades Cutáneas Genéticas/radioterapia , Terapia Ultravioleta/métodos
20.
Arq. bras. oftalmol ; 76(3): 155-158, maio-jun. 2013. ilus
Artículo en Inglés | LILACS | ID: lil-681847

RESUMEN

PURPOSE: To evaluate the thinnest corneal thickness changes during and after corneal collagen cross-linking treatment with ultraviolet-A irradiation, using hypo-osmolar riboflavin solution in thin corneas. METHODS: Eighteen eyes of 18 patients were included in this study. After epithelium removal, iso-osmolar 0.1% riboflavin solution was instilled to the cornea every 3 minutes for 30 minutes. Hypo-osmolar 0.1% riboflavin solution was then applied every 20 seconds for 5 minutes or until the thinnest corneal thickness reached 400 µm. Ultraviolet-A irradiation was performed for 30 minutes. During irradiation, iso-osmolar 0.1% riboflavin drops were applied every 5 minutes. Ultrasound pachymetry was performed at approximately the thinnest point of the cornea preoperatively, after epithelial removal, after iso-osmolar riboflavin instillation, after hypo-osmolar riboflavin instillation, after ultraviolet-A irradiation, and at 1, 6 and 12 months after treatment. RESULTS: Mean preoperative thinnest corneal thickness was 380 ± 11 µm. After epithelial removal it decreased to 341 ± 11 µm, and after 30 minutes of iso-osmolar 0.1% riboflavin drops, to 330 ± 7.6 µm. After hypo-osmolar 0.1% riboflavin drops, mean thinnest corneal thickness increased to 418 ± 11 µm. After UVA irradiation, it was 384 ± 10 µm. At 1, 6 and 12 months after treatment, it was 372 ± 10 µm, 381 ± 12.7, and 379 ± 15 µm, respectively. No intraoperative, early postoperative, or late postoperative complications were noted. CONCLUSIONS: Hypo-osmolar 0.1% riboflavin solution seems to be effective for swelling thin corneas. The swelling effect is transient and short acting. Corneal thickness should be monitored throughout the procedure. Larger sample sizes and longer follow-up are required in order to make meaningful conclusions regarding safety.


OBJETIVO: Avaliar as alterações da espessura mínima da córnea durante e após o cross-linking do colágeno corneano com radiação ultravioleta A e solução hipo-osmolar de riboflavina em córneas finas. MÉTODOS: Dezoito olhos de 18 pacientes foram incluídos neste estudo. Após a remoção do epitélio, solução iso-osmolar de riboflavina 0,1% foi instilada a cada 3 minutos por 30 minutos. Solução hipo-osmolar de riboflavina 0,1% foi então aplicada a cada 20 segundos por 5 minutos ou até que a espessura mínima da córnea atingisse 400 µm. Irradiação UVA foi feita durante 30 minutos. Durante a irradiação, riboflavina iso-osmolar 0,1% foi aplicada a cada 5 minutos. Paquimetria ultrassônica foi realizada no ponto mais fino da córnea antes da cirurgia, após a remoção do epitélio, após a instilação de riboflavina iso-osmolar, após a instilação de riboflavina hipo-osmolar, após a irradiação com UVA e após 1, 6 e 12 meses do tratamento. RESULTADOS: Antes da cirurgia, a espessura mínima da córnea era de 380 ± 11 µm. Após a remoção do epitélio, este valor foi reduzido para 341 ± 11 µm e após 30 minutos de riboflavina iso-osmolar, caiu para 330 ± 7,6 µm. Após a riboflavina hipo-osmolar, a espessura mínima da córnea aumentou para 418 ± 11 µm. Após a irradiação com UVA, era de 384 ± 10 µm. Após 1, 6 e 12 meses do tratamento este valor era de 372 ± 10, 381 ± 12,7 e 379 ± 15 µm, respectivamente. Não foram observadas complicações no intra ou no pós-operatório precoce ou tardio. CONCLUSÕES: A solução de riboflavina hipo-osmolar 0,1% parece ser eficaz para edemaciar córnea finas. Este efeito é transitório e de curta duração. A espessura da córnea deveria ser monitorada durante todo o procedimento. Maior número de casos e seguimento prolongado são necessários para tirarmos conclusões quanto à segurança.


Asunto(s)
Adolescente , Adulto , Femenino , Humanos , Masculino , Adulto Joven , Sustancia Propia/efectos de los fármacos , Sustancia Propia/efectos de la radiación , Reactivos de Enlaces Cruzados/farmacología , Riboflavina/farmacología , Terapia Ultravioleta/métodos , Complejo Vitamínico B/farmacología , Paquimetría Corneal , Colágeno/efectos de los fármacos , Colágeno/efectos de la radiación , Reactivos de Enlaces Cruzados/uso terapéutico , Queratocono/cirugía , Concentración Osmolar , Fotoquimioterapia , Estudios Prospectivos , Fármacos Fotosensibilizantes/farmacología , Fármacos Fotosensibilizantes/uso terapéutico , Riboflavina/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento , Agudeza Visual , Complejo Vitamínico B/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA